Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
Ina Research Incorporation
sales of 2.30 billion Japanese Yen [US$20.64 million]
Hester Pharmaceuticals Limited
(1.23 billion Indian Rupees [US$19.07 million]
based in India
(38.91 billion Indian Rupees [US$603.12 million]
Atect Corp reported sales of ¥2.48 billion (US$22.32 million)
March of 2017.
a very small
increase of 0.4%
versus 2016, when the company's sales were ¥2.47 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Atect Corp had sales
of ¥2.50 billion.